Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4785262
Max Phase: Preclinical
Molecular Formula: C33H46N6O11
Molecular Weight: 702.76
Molecule Type: Unknown
Associated Items:
ID: ALA4785262
Max Phase: Preclinical
Molecular Formula: C33H46N6O11
Molecular Weight: 702.76
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CCC(=O)O)C(=O)Nc1ccc2c(C)cc(=O)oc2c1
Standard InChI: InChI=1S/C33H46N6O11/c1-18(2)13-24(39-33(49)25(17-40)36-20(4)41)31(47)35-16-28(43)38-23(7-5-6-12-34-27(42)10-11-29(44)45)32(48)37-21-8-9-22-19(3)14-30(46)50-26(22)15-21/h8-9,14-15,18,23-25,40H,5-7,10-13,16-17H2,1-4H3,(H,34,42)(H,35,47)(H,36,41)(H,37,48)(H,38,43)(H,39,49)(H,44,45)/t23-,24-,25-/m0/s1
Standard InChI Key: QKNNOCYWQRABNG-SDHOMARFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 702.76 | Molecular Weight (Monoisotopic): 702.3225 | AlogP: -0.18 | #Rotatable Bonds: 20 |
Polar Surface Area: 262.34 | Molecular Species: ACID | HBA: 10 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.47 | CX Basic pKa: | CX LogP: -1.68 | CX LogD: -4.51 |
Aromatic Rings: 2 | Heavy Atoms: 50 | QED Weighted: 0.07 | Np Likeness Score: -0.30 |
1. Yang LL,Wang HL,Yan YH,Liu S,Yu ZJ,Huang MY,Luo Y,Zheng X,Yu Y,Li GB. (2020) Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery., 192 [PMID:32163813] [10.1016/j.ejmech.2020.112201] |
Source(1):